Quarterly Earnings

Cosmos Health's subsidiary will manufacture the advanced generic pain reliever PathMuscle, securing a major contract and enhancing its European footprint.

United is set to reveal its full-year 2025 earnings, putting its ambitious growth strategy and market leadership claims to the ultimate test.

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

Founder Chuck Cohn pours millions more into his ed-tech firm, a bold move that signals deep confidence despite a slumping stock and cautious analysts.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With 35 years at the company, new CEO John Baylouny plans to accelerate R&D and expand into new markets, building on a period of strong growth.

With record Q3 earnings and strong analyst ratings, Red Violet is set to present its identity intelligence growth strategy at the prestigious Needham conference.

Smart scooter giant Niu Technologies posted record annual sales driven by China, but a sharp Q4 drop, especially abroad, clouds its global outlook.

International Petroleum Corp. is ahead of schedule and on budget at its massive Blackrod oil sands project, signaling a major win for Canadian energy.

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

Principal Financial is set to unveil its 2026 forecast. Investors weigh strong 2025 results against analyst caution and shifting economic tides.

Investors eye Hexcel's Q4 2025 results for signs of an aerospace rebound, strategic shifts under new leadership, and the future of advanced composites.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Shipping giant Costamare Inc. reaffirms its financial strength with consistent shareholder payouts, backed by a strong market and strategic growth.

With a 79% drop in net loss and a fourth straight growth quarter, supplement maker Vitality Products Inc. bets on new hires to conquer online and retail.

As Wesdome Gold Mines targets mid-tier status, the appointment of financial expert Faheem Tejani signals a strategic move to bolster financial oversight.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

MENA's streaming leader Anghami doubles its subscribers after its OSN+ merger, but a $37M loss raises questions about its high-stakes growth strategy.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.